Does a blood pressure J curve exist for patients with chronic kidney disease?

Area of Science:

• Nephrology
• Cardiology
• Hypertension Management

Background:

• Aggressive blood pressure reduction can lead to adverse cardiovascular events, known as the J-curve phenomenon, particularly in specific patient groups.
• Studies involving patients with chronic kidney disease (CKD) frequently demonstrate a J-curve effect concerning cardiovascular morbidity and mortality, even after accounting for confounding variables.

Purpose of the Study:

• To evaluate the risks associated with aggressive blood pressure reduction in chronic kidney disease patients.
• To determine if stringent blood pressure targets (<130/70 mm Hg) offer renal benefits or increase cardiovascular risks.

Main Methods:

• Review of existing studies on blood pressure targets and cardiovascular outcomes in chronic kidney disease.
• Analysis of the relationship between intensive blood pressure control, renal function, and cardiovascular events.

Main Results:

• A J-curve phenomenon for cardiovascular morbidity and mortality is consistently observed in chronic kidney disease patients.
• No evidence supports improved renal outcomes with stricter blood pressure targets (<130/70 mm Hg).
• Intensive blood pressure control may impair renal function, potentially elevating cardiovascular risk.

Conclusions:

• The increased cardiovascular risk from extreme blood pressure reduction in CKD patients is undesirable.
• Intensive blood pressure management in CKD may negatively impact renal function and subsequently increase cardiovascular risk, highlighting the need for cautious target setting.